(Q46630320)

23 December 2017

title

Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination (English)

1 reference

23 December 2017

1 reference

meningococcal meningitis

1 reference

Mohammed I

1

1 reference

23 December 2017

Onyemelukwe GC

2

1 reference

23 December 2017

Obineche EN

3

1 reference

23 December 2017

Gupta N

4

1 reference

23 December 2017

Oyeyinka GO

5

1 reference

23 December 2017

publication date

1 September 1984

1 reference

23 December 2017

published in

Journal of Infection

1 reference

23 December 2017

volume

9

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

197-202

1 reference

23 December 2017

Human immunity to the meningococcus. I. The role of humoral antibodies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Response of children to Neisseria meningitidis polysaccharide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Control of meningococcal infection in the African meningitis belt by selective vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Control of epidemic meningococcal meningitis by mass vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Immunogenicity of the Group A and Group C Meningococcal Polysaccharides in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Serologic studies of meningococcal infection and polysaccharide vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

The duration of the antibody response to meningococcal vaccination in an African village

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

The immune response to a meningococcal polysaccharide vaccine in an African village

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Immunogenicity of group A and group C meningococcal polysaccharides in human infants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2884%2991468-3

7 January 2021

10.1016/S0163-4453(84)91468-3

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017